Skip to Content
Morningstar

Dr Reddy's Laboratories Ltd 500124

Morningstar Rating
Unlock
Stock XBOM Rating as of
INR 6,428.05 +56.40 (0.89%)
View Full Chart
As of Delayed Price Closed
Unlock our analysis with Morningstar Investor
Start Free Trial

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

View History
500124 is trading at a 15% premium.
Price
INR 6,375.11
Fair Value
INR 6,882.43
Uncertainty
High
1-Star Price
INR 2,282.42
5-Star Price
INR 7,685.63
Economic Moat
Jtcfw
Capital Allocation
Zkrygmtc
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 500124 is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
INR 6,371.65
Day Range
INR 6,367.95–6,524.95
52-Week Range
INR 5,042.65–6,524.95
Bid/Ask
INR 0.00 / INR 0.00
Market Cap
INR 1.07 Tril
Volume/Avg
28,818 / 13,608

Key Statistics

Price/Earnings (Normalized)
20.34
Price/Sales
3.80
Dividend Yield (Trailing)
0.63%
Dividend Yield (Forward)
0.63%
Total Yield
0.63%

Company Profile

Dr. Reddy’s is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (22% of its generics sales), Russia (12%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy’s also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy’s has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy’s also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Large Core
Total Number of Employees
27,048
Website
https://www.drreddys.com

Competitors

Valuation

View More
Metric
500124
TEVA
VTRS
Price/Earnings (Normalized)
 20.346.273.69
Price/Book Value
 3.802.580.62
Price/Sales
 3.801.160.82
Price/Cash Flow
 16.7711.643.81
Price/Earnings
500124
TEVA
VTRS

Financial Strength

Metric
500124
TEVA
VTRS
Quick Ratio
 1.840.470.66
Current Ratio
 2.580.891.67
Interest Coverage
 41.670.181.15
Quick Ratio
500124
TEVA
VTRS

Profitability

Metric
500124
TEVA
VTRS
Return on Assets (Normalized)
 15.32%6.03%7.07%
Return on Equity (Normalized)
 21.28%35.36%16.57%
Return on Invested Capital (Normalized)
 19.75%12.54%9.85%
Return on Assets
500124
TEVA
VTRS
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Drug Manufacturers - Specialty & Generic Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
XzrgrlxgddYdc$79.8 Bil
 Merck KGaA ADR
MKKGY
XqtyddpfSxcfgh$70.0 Bil
 Haleon PLC ADR
HLN
LrgvgwwxYlbf$37.3 Bil
 Teva Pharmaceutical Industries Ltd ADR
TEVA
BspflvmrFkpl$18.4 Bil
 Dr Reddy's Laboratories Ltd ADR
RDY
XvkksylBgvld$12.7 Bil
 Viatris Inc
VTRS
TxqgcdfCdtb$12.4 Bil
 Catalent Inc
CTLT
QhqwlkfGbtjfy$10.2 Bil
 Perrigo Co PLC
PRGO
RcjqjthjXpbn$3.5 Bil
 Prestige Consumer Healthcare Inc
PBH
HmjhqwhyqGhxftqz$3.4 Bil
 Curaleaf Holdings Inc
CURLF
GlnsdczDybl$2.8 Bil

Sponsor Center